Akanda Corp Financials

AKAN Stock  USD 1.54  0.04  2.67%   
Based on the analysis of Akanda Corp's profitability, liquidity, and operating efficiency, Akanda Corp may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, Akanda Corp's Non Currrent Assets Other are very stable compared to the past year. As of the 19th of March 2025, Long Term Debt is likely to grow to about 2.4 M, while Other Current Liabilities is likely to drop about 2.3 M. Key indicators impacting Akanda Corp's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Equity7.977.59
Sufficiently Up
Slightly volatile
Current Ratio0.220.16
Significantly Up
Slightly volatile
Investors should never underestimate Akanda Corp's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Akanda Corp's cash flow, debt, and profitability to make informed and accurate decisions about investing in Akanda Corp.

Net Income

(27.6 Million)

  
Understanding current and past Akanda Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Akanda Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Akanda Corp's assets may result in an increase in income on the income statement.

Akanda Corp Stock Summary

Akanda Corp competes with China SXT, Shuttle Pharmaceuticals, C21 Investments, Grown Rogue, and Lifecore Biomedical. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom. Akanda Corp is traded on NASDAQ Exchange in the United States.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINCA00971M1068
CUSIP00971M106 00971M205 00971M403 00971M304
LocationUnited Kingdom
Business Address1a, 1b Learoyd
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.akandacorp.com
Phone44 20 2498 7917
CurrencyUSD - US Dollar

Akanda Corp Key Financial Ratios

Akanda Corp Key Income Statement Accounts

202020212022202320242025 (projected)
Net Interest Income(635.0K)(1.1M)(114.4K)(255.6K)(294.0K)(308.7K)
Interest Income10.2K26.7K886.039.035.133.35
Interest Expense645.2K1.1M115.3K255.7K230.1K416.5K
Total Revenue2.1K41.4K2.6M2.2M2.5M2.6M
Gross Profit253.0(714.7K)2.0M111.4K128.2K121.8K
Operating Income(1.7M)(6.8M)(20.2M)(10.1M)(9.0M)(9.5M)
Ebit(1.7M)(2.5M)(8.1M)(32.0M)(28.8M)(27.4M)
Ebitda(1.4M)(2.2M)(4.5M)(27.7M)(25.0M)(23.7M)
Cost Of Revenue1.8K756.2K649.9K2.0M2.4M2.5M
Income Before Tax(2.3M)(8.1M)(8.2M)(32.3M)(29.0M)(27.6M)
Net Income(2.9M)(9.2M)397.0K(32.3M)(29.0M)(27.6M)
Income Tax Expense645.4K1.1M(8.6M)(1.0)(0.9)(0.94)

Akanda Corp Key Cash Accounts

202020212022202320242025 (projected)
Investments(432.2K)(576.5K)(4.2M)24.9K22.4K23.5K
Change In Cash(806.1K)3.5M(3.2M)(161.9K)(145.7K)(138.4K)
Free Cash Flow(1.8M)(7.1M)(11.8M)(1.5M)(1.4M)(1.4M)
Depreciation248.7K309.0K3.8M4.3M4.9M5.2M
Other Non Cash Items668.9K1.9M(6.3M)23.3M26.8M28.2M
Capital Expenditures439.1K576.5K310.9K1.5K1.4K1.3K
Net Income(2.3M)(8.1M)(11.7M)(32.3M)(29.0M)(27.6M)
End Period Cash Flow13.5K3.5M255.8K93.9K84.5K80.3K

Akanda Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Akanda Corp's current stock value. Our valuation model uses many indicators to compare Akanda Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akanda Corp competition to find correlations between indicators driving Akanda Corp's intrinsic value. More Info.
Akanda Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Akanda Corp's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akanda Corp's earnings, one of the primary drivers of an investment's value.

Akanda Corp Systematic Risk

Akanda Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Akanda Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Akanda Corp correlated with the market. If Beta is less than 0 Akanda Corp generally moves in the opposite direction as compared to the market. If Akanda Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Akanda Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Akanda Corp is generally in the same direction as the market. If Beta > 1 Akanda Corp moves generally in the same direction as, but more than the movement of the benchmark.

Akanda Corp Thematic Clasifications

Akanda Corp is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Today, most investors in Akanda Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Akanda Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Akanda Corp growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0355

At this time, Akanda Corp's Price Earnings To Growth Ratio is very stable compared to the past year.

Akanda Corp March 19, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Akanda Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Akanda Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Akanda Corp based on widely used predictive technical indicators. In general, we focus on analyzing Akanda Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Akanda Corp's daily price indicators and compare them against related drivers.
When determining whether Akanda Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akanda Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akanda Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akanda Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akanda Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Akanda Stock, please use our How to Invest in Akanda Corp guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akanda Corp. If investors know Akanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akanda Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(524.76)
Revenue Per Share
9.388
Quarterly Revenue Growth
2.705
Return On Assets
(0.26)
Return On Equity
(2.43)
The market value of Akanda Corp is measured differently than its book value, which is the value of Akanda that is recorded on the company's balance sheet. Investors also form their own opinion of Akanda Corp's value that differs from its market value or its book value, called intrinsic value, which is Akanda Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akanda Corp's market value can be influenced by many factors that don't directly affect Akanda Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akanda Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akanda Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akanda Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.